glp 1 medication retatrutide vs Semaglutide and Tirzepatide: GLP-3 Facts explained Retatrutide Research: Triple Agonist Mechanism
Description
Brown, B., Alphs, L., Turkoz, I
& Reboucas, N
Did someone do something wrong
This dual action might lead to better results for certain individuals
The landmark SELECT trial demonstrated that semaglutide reduces major adverse cardiovascular events in patients with overweight or obesity without diabetes, supporting expanded use of GLP-1RAs beyond glycemic control
Ozempic FDA labeling information
